Ceftriaxone-Related Encephalopathy in a Patient With End-Stage Renal Disease and High Ceftriaxone Concentrations in Cerebrospinal Fluid and Plasma: A Case Report

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2023 Nov 6

PMID 37927711

Authors

Tomonori Takano

Mayumi Kaburagi

Satoru Morikubo

Daisuke Ichikawa

Kazuaki Matsumoto

Affiliations

Soon will be listed here.

Abstract

Ceftriaxone (CTRX) does not require dose adjustment based on the renal function status and is used to treat infections. Recently, several studies reported the incidence of antibiotic-associated encephalopathy due to CTRX in patients with end-stage renal disease (ESRD). We experienced a case of CTRX-related encephalopathy in a patient on hemodialysis. When CTRX-related encephalopathy was discovered, the CTRX concentrations were measured in the blood and cerebrospinal fluid (CSF). The highest blood and CSF CTRX concentrations in this patient were 967 and 100.7 μg/mL, respectively, which were approximately 10 times higher than the CSF concentrations in a previously evaluated patient with CTRX encephalopathy. The concentration of CTRX may be increased in patients with ESRD. Hence, encephalopathy must be suspected in this patient group when CTRX is used.

References

Onogi C, Osada A, Imai K, Mimura T, Saka Y, Urahama Y . Two cases of ceftriaxone-induced encephalopathy treated by hemoperfusion in hemodialysis patients. Hemodial Int. 2022; 26(3):E27-E30. PMC: 9545014. DOI: 10.1111/hdi.13018. View

Inoue Y, Doi Y, Arisato T, Sugioka S, Koga K, Nishioka K . Three Cases of Hemodialysis Patients Receiving High-Dose Ceftriaxone: Serum Concentrations and Its Neurotoxicity. Kidney Int Rep. 2017; 2(5):984-987. PMC: 5733829. DOI: 10.1016/j.ekir.2017.03.009. View

Joynt G, Lipman J, Gomersall C, Young R, Wong E, Gin T . The pharmacokinetics of once-daily dosing of ceftriaxone in critically ill patients. J Antimicrob Chemother. 2001; 47(4):421-9. DOI: 10.1093/jac/47.4.421. View

Nishioka H, Cho Y, Irie K, Kanamori M . Ceftriaxone-associated encephalopathy in a patient with high levels of ceftriaxone in blood and cerebrospinal fluid. Int J Infect Dis. 2022; 116:223-225. DOI: 10.1016/j.ijid.2022.01.023. View

Goldwater P . Cefotaxime and ceftriaxone cerebrospinal fluid levels during treatment of bacterial meningitis in children. Int J Antimicrob Agents. 2005; 26(5):408-11. DOI: 10.1016/j.ijantimicag.2005.08.005. View

Tan S, Cockcroft M, Page-Sharp M, Arendts G, Davis T, Moore B . Population Pharmacokinetic Study of Ceftriaxone in Elderly Patients, Using Cystatin C-Based Estimates of Renal Function To Account for Frailty. Antimicrob Agents Chemother. 2020; 64(10). PMC: 7508575. DOI: 10.1128/AAC.00874-20. View

Bhattacharyya S, Darby R, Raibagkar P, Gonzalez Castro L, Berkowitz A . Antibiotic-associated encephalopathy. Neurology. 2016; 86(10):963-71. DOI: 10.1212/WNL.0000000000002455. View

Munar M, Singh H . Drug dosing adjustments in patients with chronic kidney disease. Am Fam Physician. 2007; 75(10):1487-96. View

Suzuki S, Naito S, Numasawa Y, Asada M, Shoji N, Zeniya M . Encephalopathy Induced by High Plasma and Cerebrospinal Fluid Ceftriaxone Concentrations in a Hemodialysis Patient. Intern Med. 2019; 58(12):1775-1779. PMC: 6630125. DOI: 10.2169/internalmedicine.1785-18. View

10.

Tsai D, Zam B, Tongs C, Chiong F, Sajiv C, Pawar B . Validating a novel three-times-weekly post-hemodialysis ceftriaxone regimen in infected Indigenous Australian patients-a population pharmacokinetic study. J Antimicrob Chemother. 2023; 78(8):1963-1973. PMC: 10393936. DOI: 10.1093/jac/dkad190. View

11.

Safadi S, Mao M, Dillon J . Ceftriaxone-induced acute encephalopathy in a peritoneal dialysis patient. Case Rep Nephrol. 2014; 2014:108185. PMC: 4273507. DOI: 10.1155/2014/108185. View

12.

Levison M, Levison J . Pharmacokinetics and pharmacodynamics of antibacterial agents. Infect Dis Clin North Am. 2009; 23(4):791-815, vii. PMC: 3675903. DOI: 10.1016/j.idc.2009.06.008. View

13.

Kim E, Na D, Kim E, Kim J, Son K, Chang K . MR imaging of metronidazole-induced encephalopathy: lesion distribution and diffusion-weighted imaging findings. AJNR Am J Neuroradiol. 2007; 28(9):1652-8. PMC: 8134211. DOI: 10.3174/ajnr.A0655. View

14.

Nau R, Sorgel F, Eiffert H . Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections. Clin Microbiol Rev. 2010; 23(4):858-83. PMC: 2952976. DOI: 10.1128/CMR.00007-10. View